Comprehensive Hematology and Oncology

St. Petersburg, Florida 33709

0 studies enrolling now · 3 studies all time

What they study most

Bladder Cancer, Hepatocellular Carcinoma, Microsatellite Instability-High, Myelodysplastic Syndromes, Non-small Cell Lung Cancer, Ovarian Cancer, Refractory Diffuse Large B-cell Lymphoma, Relapsed Diffuse Large B-cell Lymphoma

Studies at this site

• DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma — Recruiting now
• Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome — Stopped early
• Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors — Running, not enrolling